Brief: GlobeImmune says updated Chordoma data from phase 1 study of gi-6301 presented at connective tissue oncology society meeting
17/10/2014 11:30
Oct 17 (Reuters) - GlobeImmune Inc GBIM.O : * Updated Chordoma data from phase 1 study of gi-6301 presented at 2014 connective tissue oncology society (ctos) annual meeting * Source text for Eikon ID:nMKWCfvcha * Further company coverage GBIM.O ((Bangalore Newsroom; +1 646 223 8780))
Recent news on GlobeImmune
See all newsBrief: GlobeImmune announces updates
Brief: Globeimmune to delist and deregister common stock from Nasdaq Capital Market
Brief: GlobeImmune reports Q1 loss per share of $0.15
Brief: GlobeImmune hires Cantor Fitzgerald to assist in review of strategic alternatives
Brief: GlobeImmune says net income of $0.9 million for three months ended September 30, 2015